pillbase.ru

Veoza

Active substance: fezolinetant

fezolinetant

Centralised EU authorisationActive

Marketing holder: Astellas Pharma Europe B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 3
  • VEOZAH
    TABLET, FILM COATED · FEZOLINETANT 45 mg/1
    0469-2760
    Astellas Pharma US, Inc.
  • VEOZAH
    TABLET, FILM COATED · FEZOLINETANT 45 mg/1
    0469-2460
    Astellas Pharma US, Inc.
  • VEOZAH
    TABLET, FILM COATED · FEZOLINETANT 45 mg/1
    0469-2660
    Astellas Pharma US, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12095-0fc3-7d5a-a467-59ceb76e614c,01a12099-ad53-719a-8840-d1a1356e8725,01a12099-ad7e-76d3-afe9-63f3e07f3c7b;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005851
Registration status
Active
ATC code
G02CX06
Sources
  • product · EMA · EMEA/H/C/005851 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005851 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005851 · Verified 2026-10-09